Baltimore-based Lupin drug receives OK from FDA
Daily Record, The (Baltimore), May 16, 2007
Lupin Pharmaceuticals Inc., of Baltimore, the U.S. subsidiary of an Indian pharmaceutical manufacturer, said it received Food and Drug Administration approval of its application to market simvastatin tablets in 10, 20, 40 and 80 milligram doses. Lupin said its simvastatin tablets are the generic equivalent of Merck & Co.'s Zocor tablets for treatment of high cholesterol.
Copyright 2007 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Most Popular Business Publications
Content provided in partnership with
Presented by American Express